Up-regulation of host cell genes during interferon-γ-induced persistent Chlamydia pneumoniae infection in HL cells

Journal of Infectious Diseases

Volumn 195, Issue 2, 2007, Pages 212-219

  Mannonen, Laura ^a,b   Nikula, Tuomas ^d,e   Haveri, Anu ^c   Reinikainen, Arja ^d   Vuola, Jenni M ^c,f   Lahesmaa, Riitta ^a   Puolakkainen, Mirja ^a,b,c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d UNIVERSITY OF TURKU   (Finland)

^e The National Graduate School in Informational and Structural Biology   (Finland)

^f GLAXOSMITHKLINE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; COMPLEMENTARY DNA; CYCLIN D1; GAMMA INTERFERON; INTERFERON STIMULATED PROTEIN; INTERLEUKIN 7 RECEPTOR; SOMATOMEDIN BINDING PROTEIN 6; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL INFECTION; CELL ADHESION; CELL CYCLE REGULATION; CELL GROWTH; CHLAMYDOPHILA PNEUMONIAE; DNA MICROARRAY; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PERSISTENT INFECTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION;

CELLS, CULTURED; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; INTERFERON TYPE II; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 33846164788     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/510314     Document Type: Article

References (50)

1. Kuo CC, Jackson LA, Campbell LA, Grayston JT. Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 1995; 8:451-61.
2. Saikku P, Leinonen M, Mattila K, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988; 2:983-6.
3. Campbell LA, Kuo CC. Chlamydia pneumoniae-an infectious risk factor for atherosclerosis? Nat Rev Microbiol 2004; 2:23-32.
4. Hahn DL, Dodge RW, Golubjatnikov R. Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma. JAMA 1991; 266:225-30.
5. Bin XX, Wolf K, Schaffner T, Malinverni R. Effect of azithromycin plus rifampin versus amoxicillin alone on eradication and inflammation in the chronic course of Chlamydia pneumoniae pneumonitis in mice. Antimicrob Agents Chemother 2000; 44:1761-4.
6. Malinverni R, Kuo CC, Campbell LA, Grayston JT. Reactivation of Chlamydia pneumoniae lung infection in mice by cortisone. J Infect Dis 1995; 172:593-4.
7. Laitinen K, Laurila AL, Leinonen M, Saikku P. Reactivation of Chlamydia pneumoniae infection in mice by cortisone treatment. Infect Immun 1996; 64:1488-90.
8. Beatty WL, Byrne GI, Morrison RP. Morphologic and antigenic characterization of interferon γ-mediated persistent Chlamydia trachomatis infection in vitro. Proc Natl Acad Sci USA 1993; 90:3998-4002.
9. Summersgill JT, Sahney NN, Gaydos CA, Quinn TC, Ramirez JA. Inhibition of Chlamydia pneumoniae growth in HEp-2 cells pretreated with gamma interferon and tumor necrosis factor alpha. Infect Immun 1995; 63:2801-3.
10. Byrne GI, Ouellette SP, Wang Z, et al. Chlamydia pneumoniae expresses genes required for DNA replication but not cytokinesis during persistent infection of HEp-2 cells. Infect Immun 2001; 69:5423-9.
11. Mannonen L, Kamping E, Penttilä T, Puolakkainen M. IFN-γ induced persistent Chlamydia pneumoniae infection in HL and Mono Mac 6 cells: characterization by real-time quantitative PCR and culture. Microb Pathog 2004; 36:41-50.
12. Coombes BK, Mahony JB. DNA array analysis of altered gene expression in human endothelial cells in response to Chlamydia pneumoniae infection. Infect Immun 2001; 69:1420-7.
13. Hess S, Peters J, Bartling G, et al. More than just innate immunity: comparative analysis of Chlamydophila pneumoniae and Chlamydia trachomatis effects on host-cell gene regulation. Cell Microbiol 2003; 5:785-95.
14. Virok D, Loboda A, Kari L, et al. Infection of U937 monocytic cells with Chlamydia pneumoniae induces extensive changes in host cell gene expression. J Infect Dis 2003; 188:1310-21.
15. Shi Y, Tokunaga O. Chlamydia pneumoniae (C. pneumoniae) infection up-regulates atherosclerosis-related gene expression in human umbilical vein endothelial cells (HUVECs). Atherosclerosis 2004; 177:245-53.
16. Belland RJ, Nelson DE, Virok D, et al. Transcriptome analysis of chlamydial growth during IFN-γ-mediated persistence and reactivation. Proc Natl Acad Sci USA 2003; 100:15971-6.
17. Nicholson TL, Olinger L, Chong K, Schoolnik G, Stephens RS. Global stage-specific gene regulation during the developmental cycle of Chlamydia trachomatis. J Bacteriol 2003; 185:3179-89.
18. Rasmussen S, Eckmann L, Quayle AJ, et al. Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis. J Clin Invest 1997; 99:77-87.
19. Cles LD, Stamm WE. Use of HL cells for improved isolation and passage of Chlamydia pneumoniae. J Clin Microbiol 1990; 28:938-40.
20. Ekman MR, Grayston JT, Visakorpi R, Kleemola M, Kuo CC, Saikku P. An epidemic of infections due to Chlamydia pneumoniae in military conscripts. Clin Infect Dis 1993; 17:420-5.
21. Nikula T, West A, Katajamaa M, et al. A Human ImmunoChip cDNA microarray provides a comprehensive tool to study immune response. J Immunol Methods 2005; 303:122-34.
22. Xia M, Bumgarner RE, Lampe MF, Stamm WE. Chlamydia trachomatis infection alters host cell transcription in diverse cellular pathways. J Infect Dis 2003; 187:424-34.
23. Lad SP, Fukuda EY, Li J, de la Maza LM, Li E. Up-regulation of the JAK/STAT1 signal pathway during Chlamydia trachomatis infection. J Immunol 2005; 174:7186-93.
24. Ren Q, Robertson SJ, Howe D, Barrows LF, Heinzen RA. Comparative DNA microarray analysis of host cell transcriptional responses to infection by Coxiella burnetii or Chlamydia trachomatis. Ann NY Acad Sci 2003; 990:701-13.
25. Xia M, Suchland RJ, Bumgarner RE, Peng T, Rockey DD, Stamm WE. Chlamydia trachomatis variant with nonfusing inclusions: growth dynamic and host-cell transcriptional response. J Infect Dis 2005; 192: 1229-36.
26. Rockey DD, Viratyosin W, Bannantine JP, Suchland RJ, Stamm WE. Diversity within inc genes of clinical Chlamydia trachomatis variant isolates that occupy non-fusogenic inclusions. Microbiology 2002; 148: 2497-505.
27. Suchland RJ, Rockey DD, Bannantine JP, Stamm WE. Isolates of Chlamydia trachomatis that occupy nonfusogenic inclusions lack IncA, a protein localized to the inclusion membrane. Infect Immun 2000; 68: 360-7.
28. Yamada K, Shimaoka M, Nagayama K, Hiroi T, Kiyono H, Honda T. Bacterial invasion induces interleukin-7 receptor expression in colonic epithelial cell line, T84. Eur J Immunol 1997; 27:3456-60.
29. Ohana M, Okazaki K, Oshima C, et al. A critical role for IL-7R signaling in the development of Helicobacter felis-induced gastritis in mice. Gastroenterology 2001; 121:329-36.
30. Okamura Y, Watari M, Jerud ES, et al. The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem 2001; 276:10229-33.
31. Ariel A, Hershkoviz R, Cahalon L, et al. Induction of T cell adhesion to extracellular matrix or endothelial cell ligands by soluble or matrix-bound interleukin-7. Eur J Immunol 1997; 27:2562-70.
32. Kleba BJ, Banta E, Lindquist EA, Stephens RS. Recruitment of mammalian cell fibronectin to the surface of Chlamydia trachomatis. Infect Immun 2002; 70:3935-8.
33. Kleba B, Stephens RS. Bacteria-associated fibronectin does not enhance Chlamydia trachomatis infectivity in vitro. Microb Pathog 2005; 39: 53-5.
34. Ritchie KJ, Zhang DE. ISG15: the immunological kin of ubiquitin. Semin Cell Dev Biol 2004; 15:237-46.
35. Kim KI, Zhang DE. ISG15, not just another ubiquitin-like protein. Biochem Biophys Res Commun 2003; 307:431-4.
36. Ritchie KJ, Hahn CS, Kim KI, et al. Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection. Nat Med 2004; 10: 1374-8.
37. Giannakopoulos NV, Luo JK, Papov V, et al. Proteomic identification of proteins conjugated to ISG15 in mouse and human cells. Biochem Biophys Res Commun 2005; 336:496-506.
38. Zhao C, Denison C, Huibregtse JM, Gygi S, Krug RM. Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc Natl Acad Sci USA 2005; 102:10200-5.
39. Loeb KR, Haas AL. Conjugates of ubiquitin cross-reactive protein distribute in a cytoskeletal pattern. Mol Cell Biol 1994; 14:8408-19.
40. Dong F, Su H, Huang Y, Zhong Y, Zhong G. Cleavage of host keratin 8 by a Chlamydia-secreted protease. Infect Immun 2004; 72:3863-8.
41. Heuer D, Brinkmann V, Meyer TF, Szczepek AJ. Expression and translocation of chlamydial protease during acute and persistent infection of the epithelial HEp-2 cells with Chlamydophila (Chlamydia) pneumoniae. Cell Microbiol 2003; 5:315-22.
42. Fu M, Wang C, Li Z, Sakamaki T, Pestell RG. Minireview: cyclin D1. Normal and abnormal functions. Endocrinology 2004; 145:5439-47.
43. Stacey DW. Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells. Curr Opin Cell Biol 2003; 15:158-63.
44. Littman AJ, Jackson LA, Vaughan TL. Chlamydia pneumoniae and lung cancer: epidemiologic evidence. Cancer Epidemiol Biomarkers Prev 2005; 14:773-8.
45. Firth SM, Baxter RC. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 2002; 23:824-54.
46. Bach LA. IGFBP-6 five years on; not so "forgotten"? Growth Horm IGF Res 2005; 15:185-92.
47. Lin T-M, Campbell LA, Rosenfeld ME, Kuo C-C. Human monocyte-derived insulin-like growth factor-2 enhances the infection of human arterial endothelial cells by Chlamydia pneumoniae. J Infect Dis 2001; 183:1368-72.
48. Puolakkainen M, Kuo CC, Campbell LA. Chlamydia pneumoniae uses the mannose 6-phosphate/insulin-like growth factor 2 receptor for infection of endothelial cells. Infect Immun 2005; 73:4620-5.
49. Gieffers J, van Zandbergen G, Rupp J, et al. Phagocytes transmit Chlamydia pneumoniae from the lungs to the vasculature. Eur Respir J 2004; 23:506-10.
50. Hogan RJ, Mathews SA, Mukhopadhay S, Summersgill JT, Timms P. Chlamydial persistence: beyond the biphasic paradigm. Infect Immun 2004; 72:1843-55.